BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the successful ...
TipRanks on MSN

BioHarvest Sciences Unveils Breakthrough in Plant-Based Exosome Production

BioHarvest Sciences ( ($BHST) ) has provided an announcement. On September 10, 2025, BioHarvest Sciences announced a significant breakthrough in ...

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from ...
TipRanks on MSN

BioHarvest Sciences Files Shelf Registration for $100M Offering

BioHarvest Sciences ( (BHST) ) has shared an announcement. On September 8, 2025, BioHarvest Sciences Inc. announced the filing and effectiveness of a shelf registration statement on Form F-3 with the ...
Seeking Alpha

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

London, United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Tate & Lyle PLC ('Tate & Lyle'), a world leader in ingredient solutions for healthier and tastier food ...

BioHarvest Sciences: Growth Story Meets Valuation Reality

BioHarvest posts strong revenue growth with VINIA and CDMO gains but faces execution risks; stocks trade at a premium. See ...
techtimes

3D Bio-Printer? Artificial Human Embryos for Organ Harvest is the Next Goal for Renewal Bio

A 3D bio-printer may be something that one hears about from science fiction movies and media but it is something that is the next technology development in medical needs. A company called Renewal Bio ...